Cold Laser Therapy Market Scope And Analysis

Cold Laser Therapy Market Report Scope

Industry Developments and Future Opportunities:

The cold laser therapy market forecast can help stakeholders in this marketplace plan their growth strategies. A few initiatives taken by key players performing in the global cold laser therapy market are listed below:

• In October 2022, Multi Radiance Medical received FDA clearance for its FibroLux therapeutic laser for pain management in fibromyalgia patients. FibroLux is a handheld, noninvasive laser device with built-in protocols to guide physicians in applying therapy on affected tender points.
• In April 2022, Acclaro Corporation introduced UltraClear, a cold fiber laser technology in the US for treating wrinkles, scars, acne scars, pigmentation, enlarged pores, fine lines, and other complexion issues. This medical laser device with MIRACL (i.e., Mid IR Ablative Cold Fiber Laser) technology emits a non-visible laser of 2910 nm wavelength that maximizes tissue ablation and minimizes post-inflammatory hyperpigmentation or post-inflammatory erythema and bleeding.
• In March 2019, Colfax Corporation completed its previously announced acquisition of DJO Global, Inc. from an investor group managed by Blackstone for US$ 3.15 billion.

Competitive Landscape and Key Companies:

Bioventus LLC, Lumenis Ltd, BTL Industries Inc, Dynatronics Corporation, Zimmer MedizinSysteme GmbH, Theralase Technologies Inc, Erchonia Corporation, ASA Laser S.p.A., Radiancy Inc, and Biolase Inc are among the key players profiled in the cold laser therapy market report. These companies adopt product development strategies to meet growing customer demands, which allows them to maintain their brand name in the market.